Annual Report 2021
Division of Surveillance and Policy Evaluation
Kota Katanoda, Eiko Saito, Kayo Togawa, Sayaka Ikeda, Sayo Tanaka, Nguyen The Phuong, Yan Kwan Lau, Byron Seiya Sigel, Hiroko Takamatsu, Rie Daiten, Reiko Sakano
Introduction
The Division of Surveillance and Policy Evaluation develops and analyzes comprehensive cancer statistics information including cancer registry data to contribute to the development and evaluation of evidence-based cancer control.
The Team and What We Do
With the aim of clarifying the cancer burden in our society and realizing optimal cancer control policies, our research focuses on descriptive epidemiology and policy evaluation by leveraging national and international cancer statistics, geographic information systems (GISs), and other sources of information. More specifically, we describe cancer trends, geographical patterns, prevention, screening, and other phases of the cancer control continuum, and also evaluate cancer control measures using mathematical approaches such as simulation modelling and health economics.
Research activities
1. Cancer statistics website "Cancer Information Service"
Cancer statistics data and graphical information such as cancer incidence, mortality and survival are provided on the website “Cancer Information Service”, managed by Institute for Cancer Control. Our analysis using cancer statistics information is published as a scientific publication in the Japanese Journal of Clinical Oncology (JJCO) and other academic journals. For the general public, the booklet "Cancer Statistics" is also published annually. This fiscal year, we provided cancer mortality data for 2020 and cancer incidence data for 2018 and published the booklet "Cancer statistics in Japan 2022".
2).nbsp;Research on cancer statistics and cancer control
Cancer statistics information is analyzed and combined with information on cancer prevention, early detection, diagnosis, treatment, palliative care, and health economics to develop and evaluate cancer control policies. This fiscal year, the secular trends in cancer incidence and mortality were analyzed using representative Japanese data; estimation of the effects of colorectal cancer screening policies was performed using micro-simulation modelling; and the histology- and stage-specific lung cancer trends were estimated using a multiple imputation technique.
3. Others
Our research activities also cover a variety of analysis on cancer and lifestyle-related disease prevention, early detection, treatment, etc. In this fiscal year, the association between the use of heated tobacco products and nicotine dependence was examined.
Education
Graduate students were openly recruited in our division under the framework of a joint graduate school in the field of Cancer Statistics and Informatics in collaboration with Osaka University Graduate School of Medicine. We also provide a training course in public health at Teikyo University School of Medicine.
Future Prospects
Based on the development and analysis of cancer statistics information, we aim to realize effective and efficient cancer control measures throughout the cancer control continuum from prevention to treatment and palliative care.
List of papers published in 2021
Journal
1. Saito E, Yano T, Hori M, Yoneoka D, Matsuda T, Chen Y, Katanoda K. Is young-onset esophageal adenocarcinoma increasing in Japan? An analysis of population-based cancer registries. Cancer medicine, 11:1347-1356, 2022
2. Katanoda K, Ideno Y, Maruoka N, Nagai K, Tsukada Y, Matsuki M, Higashi T, Hayashi K. Validation of Identifying Cancer Diagnosis Based on Self-Reported Information in the Japan Nurses' Health Study. Asian Pacific journal of cancer prevention: APJCP, 23:651-657, 2022
3. Shin S, Lee JE, Loftfield E, Shu XO, Abe SK, Rahman MS, Saito E, Islam MR, Tsugane S, Sawada N, Tsuji I, Kanemura S, Sugawara Y, Tomata Y, Sadakane A, Ozasa K, Oze I, Ito H, Shin MH, Ahn YO, Park SK, Shin A, Xiang YB, Cai H, Koh WP, Yuan JM, Yoo KY, Chia KS, Boffetta P, Ahsan H, Zheng W, Inoue M, Kang D, Potter JD, Matsuo K, Qiao YL, Rothman N, Sinha R. Coffee and tea consumption and mortality from all causes, cardiovascular disease and cancer: a pooled analysis of prospective studies from the Asia Cohort Consortium. International journal of epidemiology, 51:626-640, 2022
4. Kamo KI, Fukui K, Ito Y, Nakayama T, Katanoda K. How much can screening reduce colorectal cancer mortality in Japan? Scenario-based estimation by microsimulation. Japanese journal of clinical oncology, 52:221-226, 2022
5. Ohmomo H, Harada S, Komaki S, Ono K, Sutoh Y, Otomo R, Umekage S, Hachiya T, Katanoda K, Takebayashi T, Shimizu A. DNA Methylation Abnormalities and Altered Whole Transcriptome Profiles after Switching from Combustible Tobacco Smoking to Heated Tobacco Products. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 31:269-279, 2022
6. Nakata K, Hiyama E, Katanoda K, Matsuda T, Tada Y, Inoue M, Kawa K, Maru M, Shimizu C, Horibe K, Miyashiro I. Cancer in adolescents and young adults in Japan: epidemiology and cancer strategy. International journal of clinical oncology, 27:7-15, 2022
7. Martellucci CA, Morettini M, Brotherton JML, Canfell K, Manzoli L, Flacco ME, Palmer M, Rossi PG, Martellucci M, Giacomini G, D’Errico MM, Pasqualini F . Impact of a Human Papillomavirus Vaccination Program within Organized Cervical Cancer Screening: Cohort Study. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 31:588-594, 2022
8. Martellucci CA, Flacco ME, Morettini M, Giacomini G, Palmer M, Fraboni S, Pasqualini F. Wide variability in colorectal cancer screening uptake by general practitioner: Cross-sectional study. Journal of medical screening, 29:21-25, 2022
9. Katanoda K. Message From the New Editor-in-Chief. Journal of epidemiology, 32:1, 2022
10. Nguyen PT, Katanoda K, Saito E, Hori M, Nakayama T, Matsuda T. Trends in lung cancer incidence by gender, histological type and stage at diagnosis in Japan, 1993 to 2015: A multiple imputation approach. International journal of cancer, 151:20-32, 2022
11. Takeuchi E, Katanoda K, Cheli S, Goldzweig G, Tabuchi T. Restrictions on healthcare utilization and psychological distress among patients with diseases potentially vulnerable to COVID-19; the JACSIS 2020 study. Health psychology and behavioral medicine, 10:229-240, 2022
12. Mizuno T, Yoshida T, Sunami K, Koyama T, Okita N, Kubo T, Sudo K, Shimoi T, Ueno H, Saito E, Katanoda K, Shibata T, Yonemori K, Okusaka T, Boku N, Ohe Y, Hiroshima Y, Ueno M, Kuboki Y, Doi T, Nakamura K, Kohno T, Yatabe Y, Yamamoto N. Study protocol for NCCH1908 (UPFRONT-trial): a prospective clinical trial to evaluate the feasibility and utility of comprehensive genomic profiling prior to the initial systemic treatment in advanced solid tumour patients. Japanese journal of clinical oncology, 51:1757-1760, 2021
13. Svensson T, Saito E, Svensson AK, Melander O, Orho-Melander M, Mimura M, Rahman S, Sawada N, Koh WP, Shu XO, Tsuji I, Kanemura S, Park SK, Nagata C, Tsugane S, Cai H, Yuan JM, Matsuyama S, Sugawara Y, Wada K, Yoo KY, Chia KS, Boffetta P, Ahsan H, Zheng W, Kang D, Potter JD, Inoue M. Association of Sleep Duration With All- and Major-Cause Mortality Among Adults in Japan, China, Singapore, and Korea. JAMA network open, 4:e2122837, 2021
14. Abe SK, Narita S, Saito E, Sawada N, Shimazu T, Goto A, Yamaji T, Iwasaki M, Inoue M, Tsugane S. Body Mass Index, Height, Weight Change, and Subsequent Lung Cancer Risk: The Japan Public Health Center-Based Prospective Study. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 30:1708-1716, 2021
15. Sasaki Y, Abe Y, Shoji M, Mizumoto N, Takeda H, Oizumi H, Yaoita T, Sawada N, Yamagishi K, Saito E, Watanabe M, Ishizawa K, Konta T, Kayama T, Tsugane S, Ueno Y, Inoue M. Reliability of self-reported questionnaire for epidemiological investigation of Helicobacter pylori eradication in a population-based cohort study. Scientific reports, 11:15605, 2021
16. Katanoda K, Hori M, Saito E, Shibata A, Ito Y, Minami T, Ikeda S, Suzuki T, Matsuda T. Updated Trends in Cancer in Japan: Incidence in 1985-2015 and Mortality in 1958-2018-A Sign of Decrease in Cancer Incidence. Journal of epidemiology, 31:426-450, 2021
17. Yang JJ, Yu D, Shu XO, Freedman ND, Wen W, Rahman S, Abe SK, Saito E, Gupta PC, He J, Tsugane S, Gao YT, Xiang YB, Yuan JM, Tomata Y, Tsuji I, Sugawara Y, Matsuo K, Ahn YO, Park SK, Chen Y, Pan WH, Pednekar M, Gu D, Sawada N, Cai H, Li HL, Koh WP, Wang R, Zhang S, Kanemura S, Ito H, Shin MH, Wu PE, Yoo KY, Ahsan H, Chia KS, Boffetta P, Inoue M, Kang D, Potter JD, Zheng W. Quantifying the association of low-intensity and late initiation of tobacco smoking with total and cause-specific mortality in Asia. Tobacco control, 30:328-335, 2021
18. Inoue-Choi M, Freedman ND, Saito E, Tanaka S, Hirabayashi M, Sawada N, Tsugane S, Usui Y, Ito H, Wang C, Tamakoshi A, Takeuchi T, Kitamura Y, Utada M, Ozasa K, Sugawara Y, Tsuji I, Wada K, Nagata C, Shimazu T, Mizoue T, Matsuo K, Naito M, Tanaka K, Katanoda K, Inoue M. Low-intensity cigarette smoking and mortality risks: a pooled analysis of prospective cohort studies in Japan. International journal of epidemiology, 2021
19. Yang JJ, Yu D, Shu XO, Wen W, Rahman S, Abe S, Saito E, Gupta PC, He J, Tsugane S, Gao YT, Yuan JM, Koh WP, Sadakane A, Tomata Y, Tsuji I, Sugawara Y, Matsuo K, Ahn YO, Park SK, Chen Y, Inoue M, Kang D, Zheng W. Reduction in total and major cause-specific mortality from tobacco smoking cessation: a pooled analysis of 16 population-based cohort studies in Asia. International journal of epidemiology, 2021
20. Charvat H, Saito E. Age-specific larynx cancer incidence rate in the world. Japanese journal of clinical oncology, 51:1181-1182, 2021
21. Palmer M, Katanoda K, Saito E, Martellucci CA, Ostuki S, Nomura S, Ota E, Brotherton JML, Hocking J. National genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: a systematic review and meta-analysis protocol. Systematic reviews, 10:135, 2021
22. Saito E, Inoue M, Sawada N, Kokubo Y, Yamagishi K, Iso H, Shimazu T, Yamaji T, Iwasaki M, Tsugane S. Risk of stroke in cancer survivors using a propensity score-matched cohort analysis. Scientific reports, 11:5599, 2021
23. Hori M, Tanaka H, Saito E, Wakai K, Katanoda K. Response to the Dr Shikata's letter: 'Secondhand smoke exposure and risk of lung cancer in Japan: a systematic review and meta-analysis of epidemiologic studies'. Japanese journal of clinical oncology, 51:661, 2021
24. Acuti Martellucci C, Nomura S, Yoneoka D, Ueda P, Brotherton J, Canfell K, Palmer M, Manzoli L, Giorgi Rossi P, De Togni A, Palmonari C, Califano A, Saito E, Hashizume M, Shibuya K. Human papillomavirus vaccine effectiveness within a cervical cancer screening programme: cohort study. BJOG: an international journal of obstetrics and gynaecology, 128:532-539, 2021
25. Toyoda Y, Katanoda K, Ishii K, Yamamoto H, Tabuchi T. Negative impact of the COVID-19 state of emergency on breast cancer screening participation in Japan. Breast cancer (Tokyo, Japan), 28:1340-1345, 2021
26. Lau YK, Okawa S, Meza R, Katanoda K, Tabuchi T. Nicotine dependence of cigarette and heated tobacco users in Japan, 2019: a cross-sectional analysis of the JASTIS Study. Tobacco control, 2021
27. Katanoda K, Ito Y, Sobue T. International comparison of trends in cancer mortality: Japan has fallen behind in screening-related cancers. Japanese journal of clinical oncology, 51:1680-1686, 2021
28. Fong GT, Yuan J, Craig LV, Xu SS, Meng G, Quah ACK, Seo HG, Lee S, Yoshimi I, Katanoda K, Tabuchi T. Achieving the Goals of Healthy China 2030 Depends on Increasing Smoking Cessation in China: Comparative Findings from the ITC Project in China, Japan, and the Republic of Korea. China CDC weekly, 3:463-467, 2021
29. Togawa K, Leon ME, Lebailly P, Beane Freeman LE, Nordby KC, Baldi I, MacFarlane E, Shin A, Park S, Greenlee RT, Sigsgaard T, Basinas I, Hofmann JN, Kjaerheim K, Douwes J, Denholm R, Ferro G, Sim MR, Kromhout H, Schüz J . Cancer incidence in agricultural workers: Findings from an international consortium of agricultural cohort studies (AGRICOH). Environment international, 157:106825, 2021
30. Togawa K, Ma H, Smith AW, Neuhouser ML, George SM, Baumgartner KB, McTiernan A, Baumgartner R, Ballard RM, Bernstein L. Self-reported symptoms of arm lymphedema and health-related quality of life among female breast cancer survivors. Scientific reports, 11:10701, 2021
31. Onyije FM, Hosseini B, Togawa K, Schüz J, Olsson A . Cancer Incidence and Mortality among Petroleum Industry Workers and Residents Living in Oil Producing Communities: A Systematic Review and Meta-Analysis. International journal of environmental research and public health, 18:2021
32. Sitas F, Hawari F, Dresler C, Stewart B, Togawa K, Zain Z, Warren G. Call for papers: Special supplement ? Tobacco cessation after a cancer diagnosis. Cancer Epidemiology, 71:101884, 2021
33. Le PM, Nguyen PT, Nguyen HV, Bui DH, Vo SH, Nguyen NV, Nguyen TV, Tran AT, Le AD, Ha NM, Dao AT, Gilmour S. Adherence to highly active antiretroviral therapy among people living with HIV and associated high-risk behaviours and clinical characteristics: A cross-sectional survey in Vietnam. International journal of STD & AIDS, 32:911-918, 2021
34. Nguyen PT, Rahman MS, Le PM, Nguyen HV, Vu KD, Nguyen HL, Dao ATM, Khuong LQ, Hoang MV, Gilmour S. Trends in, projections of, and inequalities in reproductive, maternal, newborn and child health service coverage in Vietnam 2000-2030: A Bayesian analysis at national and sub-national levels. The Lancet regional health. Western Pacific, 15:100230, 2021
35. Nguyen TP, Wong ZS, Wang L, Thanh TT, Van Nguyen H, Gilmour S. Rapid impact assessments of COVID-19 control measures against the Delta variant and short-term projections of new confirmed cases in Vietnam. Journal of global health, 11:3118, 2021
36. Katanoda K, Hirabayashi M, Saito E, Hori M, Abe SK, Matsuda T, Inoue M, the Cancer PAF Japan Collaborators. Burden of cancer attributable to tobacco smoke in Japan in 2015 . Global health & medicine, 1:43-50, 2021
37. Hori M, Katanoda K, Ueda K, Nakaya T, Saito E, Abe SK, Hirabayashi M, Matsuda T, Inoue M, the Cancer PAF Japan Collaborators. Burden of cancer attributable to modifiable factors in Japan in 2015. Global health & medicine, 1:76-84, 2021
38. Corbin S, Togawa K, Schüz J, Le Cornet C, Fervers B, Feychting M, Wiebert P, Hansen J, Dalton SO, Kjærheim K, Nordby KC, Østrem RS, Skakkebæk NE, Uuksulainen S, Pukkala E, Olsson A . Parental occupational exposures in wood-related jobs and risk of testicular germ cell tumours in offspring in NORD-TEST a registry-based case-control study in Finland, Norway, and Sweden. International archives of occupational and environmental health, 2021
39. Acuti Martellucci C, Morettini M, Flacco ME, Manzoli L, Palmer M, Giacomini G, Pasqualini F. Delivering cervical cancer screening during the COVID-19 emergency. BMJ sexual & reproductive health, 47:296-299, 2021
40. Zhu J, Smith-Warner SA, Yu D, Zhang X, Blot WJ, Xiang YB, Sinha R, Park Y, Tsugane S, White E, Koh WP, Park SK, Sawada N, Kanemura S, Sugawara Y, Tsuji I, Robien K, Tomata Y, Yoo KY, Kim J, Yuan JM, Gao YT, Rothman N, Lazovich D, Abe SK, Rahman MS, Loftfield E, Takata Y, Li X, Lee JE, Saito E, Freedman ND, Inoue M, Lan Q, Willett WC, Zheng W, Shu XO. Associations of coffee and tea consumption with lung cancer risk. International journal of cancer, 2020